PATENT CLAIM ANALYSIS

Application Number: 16239222
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "488000"]

Abstract:
This disclosure relates to extended release oral dosage forms comprising a matrix containing a viscosity modifier (but no lipid) and coated granules containing a high water-soluble, high dose drug. The dosage forms have alcohol resistance and may also have crush resistance.

Claim (Index 8):
The dosage form of  claim 1 , wherein the first and second strong film formers are independently selected from the group consisting of: natural and synthetic starches, natural and synthetic celluloses, acrylics, vinylics, resins, methacrylate or shellac.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.27778
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14296572', '13721128', '14527215', '14539231', '15210760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8232115489180415
- 35 USC 102 Novelty (BERT): 0.5363736735620325
- Combined Prediction Score: 0.7945277613824406
- Mean Citation Score: 287.088994
- Max Citation Score: 368.59885
- Similarity Product: 300.8968988994867

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test